相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Targeting epigenetic regulators for cancer therapy
Susan Wee et al.
ANNALS REPORTS (2014)
Targeting the STAT3 signaling pathway in cancer: Role of synthetic and natural inhibitors
Kodappully Sivaraman Siveen et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2014)
Epigenetics and Oncology
Padmaja Mummaneni et al.
PHARMACOTHERAPY (2014)
EZH2 overexpression in natural killer/T-cell lymphoma confers growth advantage independently of histone methyltransferase activity
Junli Yan et al.
BLOOD (2013)
MYC status in concert with BCL2 and BCL6 expression predicts outcome in diffuse large B-cell lymphoma
Heike Horn et al.
BLOOD (2013)
Linking JNK-STAT3-Akt signaling axis to EZH2 phosphorylation: A novel pathway of carcinogenesis
Yon Rojanasakul
CELL CYCLE (2013)
Identification of EZH2 and EZH1 Small Molecule Inhibitors with Selective Impact on Diffuse Large B Cell Lymphoma Cell Growth
Shivani Garapaty-Rao et al.
CHEMISTRY & BIOLOGY (2013)
Disruption of the MYC-miRNA-EZH2 loop to suppress aggressive B-cell lymphoma survival and clonogenicity
X. Zhao et al.
LEUKEMIA (2013)
被撤回的出版物: Coordinated Silencing of MYC-Mediated miR-29 by HDAC3 and EZH2 as a Therapeutic Target of Histone Modification in Aggressive B-Cell Lymphomas (Retracted article. See vol. 41, pg. 1198, 2023)
Xinwei Zhang et al.
CANCER CELL (2012)
A key role for EZH2 and associated genes in mouse and human adult T-cell acute leukemia
Camille Simon et al.
GENES & DEVELOPMENT (2012)
EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations
Michael T. McCabe et al.
NATURE (2012)
Genetic inactivation of the polycomb repressive complex 2 in T cell acute lymphoblastic leukemia
Panagiotis Ntziachristos et al.
NATURE MEDICINE (2012)
Immunohistochemical Detection of MYC-driven Diffuse Large B-Cell Lymphomas
Michael J. Kluk et al.
PLOS ONE (2012)
Selective inhibition of Ezh2 by a small molecule inhibitor blocks tumor cells proliferation
Wei Qi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Therapeutic prospects for epigenetic modulation
Tom D. Heightman
EXPERT OPINION ON THERAPEUTIC TARGETS (2011)
Activated oncogenic pathways and therapeutic targets in extranodal nasal-type NK/T cell lymphoma revealed by gene expression profiling
Siok-Bian Ng et al.
JOURNAL OF PATHOLOGY (2011)
Myc Enforces Overexpression of EZH2 in Early Prostatic Neoplasia via Transcriptional and Post-transcriptional Mechanisms
Cheryl M. Koh et al.
ONCOTARGET (2011)
Rearrangement of MYC Is Associated With Poor Prognosis in Patients With Diffuse Large B-Cell Lymphoma Treated in the Era of Rituximab
Sharon Barrans et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders
Thomas Ernst et al.
NATURE GENETICS (2010)
MYC stimulates EZH2 expression by repression of its negative regulator miR-26a
Sandrine Sander et al.
BLOOD (2008)
MYC translocation and an increased copy number predict poor prognosis in adult diffuse large B-cell lymphoma (DLBCL), especially in germinal centre-like B cell (GCB) type
S. O. Yoon et al.
HISTOPATHOLOGY (2008)
Constitutively activated STAT3 promotes cell proliferation and survival in the activated B-cell subtype of diffuse large B-cell lymphomas
B. Belinda Ding et al.
BLOOD (2008)
EZH2 promotes proliferation and invasiveness of prostate cancer cells
R. J. Bryant et al.
PROSTATE (2007)
The polycomb group gene Ezh2 prevents hematopoietic stem cell exhaustion
LM Kamminga et al.
BLOOD (2006)
EZH2 expression is associated with high proliferation rate and aggressive tumor subgroups in cutaneous melanoma and cancers of the endometrium, prostate, and breast
IM Bachmann et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Histone demethylation by hydroxylation: Chemistry in action
Jessica Schneider et al.
ACS CHEMICAL BIOLOGY (2006)
Akt-mediated phsophorylationof EZH2 suppresses methylation of lysine 27 in histone H3
TL Cha et al.
SCIENCE (2005)
The International Prognostic Index determines the outcome of patients with nodal mature T-cell lymphomas
R Sonnen et al.
BRITISH JOURNAL OF HAEMATOLOGY (2005)
Epigenetics in human disease and prospects for epigenetic therapy
G Egger et al.
NATURE (2004)
EZH2 is downstream of the pRB-E2F pathway, essential for proliferation and amplified in cancer
AP Bracken et al.
EMBO JOURNAL (2003)
Loss of expression of the WNT/β-catenin-signaling pathway transcription factors lymphoid enhancer factor-1 (LEF-1) and T cell factor-1 (TCF-1) in a subset of peripheral T cell lymphomas
DM Dorfman et al.
AMERICAN JOURNAL OF PATHOLOGY (2003)
The Polycomb group protein EZH2 is upregulated in proliferating, cultured human mantle cell lymphoma
HPJ Visser et al.
BRITISH JOURNAL OF HAEMATOLOGY (2001)
分享论文
